Expanding Existing Businesses Under the New Three-Year Management Plan

「We made maximum use of the organic synthesis technologies in which we specialize, strengthened the development of high-value-added products, expanded contract-manufactured products and actively pursued market expansion in growth fields, including electronic materials and products for pharmaceutical applications.」

「Against this backdrop, toward the final year of ACCEL2026, the five-year medium-term management plan beginning in 2022 and covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026,” the Group implemented growth investments to increase production capacity and cost-reduction initiatives, while creating an environment for flexible use of existing facilities. It is responding to demand for organic compounds in growth markets such as semiconductor materials and pharmaceutical applications, strengthening the development of high-value-added products by leveraging its long-established organic synthesis technologies, and establishing a system capable of responding closely to customer requirements as it pursues its targets.」

「Against this backdrop, to realize ACCEL2026, the five-year medium-term management plan beginning in 2022 and covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026,” the Group made growth investments in its existing multi-purpose plant during the current fiscal year to increase production capacity. It also prepared to achieve its targets by expanding contract-manufactured products, promoting new product development, pursuing market expansion, and putting the necessary preparations in place.」

「The current fiscal year marks the midpoint of ACCEL2026, the medium-term management plan beginning in 2022 and covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026.” To achieve its targets, the company is making growth investments in its existing multi-purpose plant to rapidly and flexibly use its contract synthesis technologies developed over the years and pursue market expansion for high-value-added new products.」

「Against this backdrop, to achieve the targets set out in the medium-term management plan beginning in 2022, covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026,” ACCEL2026—“Driving innovation powerfully and accelerating growth”—the Group is investing in equipment for its existing multi-purpose plant to increase production capacity while further expanding contract-synthesized products, promoting new product development, and pursuing market expansion.」

「Against this backdrop, to achieve the targets set out in the medium-term management plan beginning in 2022, covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026,” ACCEL2026—“Driving innovation powerfully and accelerating growth”—the Group decided to invest in equipment for its existing multi-purpose plant to increase production capacity while further expanding contract-synthesized products, promoting new product development, and pursuing market expansion using its proprietary synthesis technologies.」

「Against this backdrop, the Group is pursuing a medium-term management plan positioning growth and enhanced corporate value as objectives, covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026.” It actively allocated management resources to expand contract-synthesized products, develop and propose environmentally compliant rubber chemicals addressing market needs in the medical rubber-use products business, where it has advantages in quality and technology, and introduce new products to the electronic materials market using its proprietary synthesis technologies, thereby achieving results and expanding markets in growth fields.」

「Against this backdrop, the Group launched a medium-term management plan beginning in 2022, covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026.” To enhance corporate value and achieve its targets, it pursued the selective allocation and concentration of management resources and strengthened its management foundation,」

「Against this backdrop, the Group launched a medium-term management plan beginning in 2022, covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026.” To enhance corporate value and achieve its targets, it used its proprietary synthesis technologies developed over the years to expand contract-synthesized products, and focused on the manufacture and sale of medical rubber-use products, dehydration-condensation agents for medical applications, and products for electronic materials applications, all with advantages in quality and technology, while actively pursuing market expansion in growth fields.」

「Against this backdrop, the Group launched a medium-term management plan beginning in 2022, covering the 121st fiscal year, “2022,” through the 125th fiscal year, “2026.” To achieve its targets, it used its proprietary synthesis technologies developed over the years to expand contract-synthesized products, focused on the manufacture and sale of medical rubber-use products with advantages in quality and technology and dehydration-condensation agents for medical applications, and actively pursued market expansion in growth fields.」

「One year has passed since the medium-term management plan ACCEL2026, beginning in the 121st fiscal year (the fiscal year ended November 2022) and covering the period from the 121st fiscal year (the fiscal year ended November 2022) through the 125th fiscal year (the fiscal year ending November 2026), was launched. “By continuously implementing the five business strategies set out in the medium-term management plan, we will respond flexibly to anticipated changes in social conditions and enhance corporate value.”」

「Against this backdrop, the Group launched a medium-term management plan beginning in 2021, covering the 121st fiscal year, “2021,” through the 125th fiscal year, “2026.” To achieve its targets, it closely monitored demand fluctuations in the market, developed high-performance products in response to customer needs, expanded contract-synthesized products using its proprietary synthesis technologies developed over the years, focused on the manufacture and sale of medical rubber-use products with advantages in quality and technology and dehydration-condensation agents for medical applications, and actively pursued market expansion in growth fields.」

「The Group formulated a medium-term management plan beginning in 2021, covering the 121st fiscal year, “2021,” through the 125th fiscal year, “2026.” To achieve its targets, it is closely monitoring demand fluctuations in the market, focusing on expanding existing businesses, and actively working to ensure stable supply,」

「The three-year management plan beginning in the 118th fiscal year ended in the 120th fiscal year (the fiscal year ended November 2021). Although the business environment changed significantly in Japan and overseas as the global spread of COVID-19 had yet to subside, in the final year the company secured its supply system and met increased customer demand. Although net sales fell short of the plan, operating income, ordinary income, and net income attributable to owners of the parent significantly exceeded their targets, aided by the adoption of new high-value-added products.」

「Against this backdrop, the Group actively worked to ensure stable supply in response to market demand fluctuations. It also used the technologies developed over the years to expand contract-synthesized products, focused on the manufacture and sale of medical rubber-use products with advantages in quality and technology and dehydration-condensation agents for medical applications, and actively pursued market expansion in growth fields.」

「Against this backdrop, the Group actively worked to ensure stable supply in response to market demand fluctuations, while focusing on the manufacture and sale of contract-synthesized products, medical rubber-use products with advantages in quality and technology, and dehydration-condensation agents for medical applications, and worked to expand markets in growth fields.」

「Against this backdrop, the Group actively worked to ensure stable supply in response to market demand fluctuations, while focusing on the manufacture and sale of contract-synthesized products and products with advantages in quality and technology, and worked to expand its business in growth fields.」

「Against this backdrop, the Group addressed demand fluctuations in rapidly deteriorating domestic and overseas markets across the entire company, while focusing on the manufacture and sale of contract-synthesized products, which were seeing rising demand, and medical and pharmaceutical-use products with advantages in quality and technology.」

「Against this backdrop, the Group addressed demand fluctuations in rapidly changing domestic and overseas markets across the entire company, while focusing on the manufacture and sale of contract-synthesized products, which were seeing rising demand, and medical and pharmaceutical-use products with advantages in quality and technology.」

「Against this backdrop, the Group actively worked to ensure stable supply in response to demand fluctuations in rapidly changing domestic and overseas markets, while focusing on the manufacture and sale of contract-synthesized products and products with advantages in quality and technology.」

「We have formulated a new three-year management plan beginning in the 118th fiscal year and will implement the following specific initiatives to improve business performance.」

「Against this backdrop, we focused on responding to new demand and fluctuations in customer demand in Japan and overseas, and on developing and introducing new products.」

「Against this backdrop, we focused on meeting new demand, introducing new products, and responding proactively to fluctuations in demand in Japan and overseas, with the result that」

「Against this backdrop, we focused on meeting demand from existing customers, introducing new products, and developing new customers in Japan and overseas, with the result that」

「We will review the three-year management plan annually, work to improve profitability and strengthen our business structure, and respond promptly to changes in management conditions. Accordingly, we will review the three-year management plan annually, work to improve profitability and strengthen our business structure, and respond promptly to changes in management conditions.」

「Against this backdrop, we focused on expanding existing businesses and developing new customers in Japan and overseas, while conducting sales proposals for new products. We also expanded our research and quality assurance facilities to meet customer requirements in Japan and overseas.」

「Against this backdrop, we focused on expanding existing businesses, introducing new products, and developing new customers in Japan and overseas in response to changes in the market, although」

「Against this backdrop, we focused on expanding existing businesses and developing new customers in Japan and overseas. As a result, sales of organic rubber chemicals for both the domestic and overseas markets exceeded the year-earlier period.」

「Against this backdrop, we focused on expanding existing businesses, developing new customers in Japan and overseas, and securing orders amid a gradual market recovery. As a result, sales of rubber chemicals for both the domestic and overseas markets exceeded the year-earlier period.」

「Following the previous fourth quarter, we focused on expanding existing businesses, developing new customers in Japan and overseas, and securing orders. As the yen remained weaker year on year, sales of rubber chemicals for both the domestic and overseas markets exceeded the year-earlier period.」

「To achieve the objectives of this management plan, we promoted efforts to expand existing businesses, develop new products, and develop new customers in Japan and overseas. We also achieved certain results by continuing to reduce costs through thorough rationalization and optimize inventories in line with order trends. In the 116th fiscal period, we will continue to expand our business by executing our growth strategy, targeting sales of ¥7.0 billion in the 117th fiscal period, the final year of the plan.」

「The Group promoted efforts to expand existing businesses under the new three-year management plan, develop new products, and develop new customers in Japan and overseas.」

「Against this backdrop, the Group strengthened its efforts to expand existing businesses under the new three-year management plan, promote the development of new products, and develop new customers in Japan and overseas.」